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Disorders of gait and balance are among the more common
clinical complaints, particularly among older patients.1 Be-
cause so many medical and neurologic conditions can influ-
ence balance and ambulation, a thorough evaluation is often
necessary. Thus, a neurologic examination, brain imaging,
and sometimes electrophysiologic studies are done to identi-
fy contributing causes and to assess and to try to reduce the
risk of falling.2
In many instances, the history and examination reveal the
likely causes. In other cases, brain magnetic resonance imag-
ing (MRI), spine MRI studies, electromyography, and nerve
conduction studies are necessary to confirm the likely mech-
anism. In some instances, even after a thorough neurologic
history and examination and extensive imaging studies the
cause of the imbalance or gait disturbance remains unclear.
Commonly, a multitude of contributing factors separately
contribute to disturbance of gait or balance. Other times,
no convincing cause can be determined. ►Table 1 lists dis-
orders that may present with gait ataxia.
This review will focus on selected causes of imbalance or
disturbed gait that may be overlooked even in the face of a
thorough neurologic, imaging and electrophysiological
evaluation.
Drug-Induced Gait Ataxia
Ataxia is a common manifestation of many drugs and toxins.
For instance, most of the antiepileptic agents have ataxia as a
relatively common acute adverse event; phenytoin, pheno-
barbital, and carbamazepine, in particular, may also have a
dose-related adverse effect on balance.3
However, there are several agents that warrant discussion
as it might not be obvious that the drug is the causative agent
primarily because the onset of gait disturbance may be quite
delayed, mimicking a degenerative condition.
Lithium Ataxia
Lithium is an agent primarily used for mood stabilization in
bipolar illness. Because of the narrow therapeutic window
and need for blood monitoring, it is less commonly used in
favor of agents such as quetiapine and lamotrigine. However,
many patients are still chronically receiving treatment with
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disorders with normal imaging.
Issue Theme Neuro-Otology 2013;
Guest Editor, Terry D. Fife, MD
Copyright © 2013 by Thieme Medical
Publishers, Inc., 333 Seventh Avenue,
New York, NY 10001, USA.
Tel: +1(212) 584-4662.
DOI http://dx.doi.org/
10.1055/s-0033-1354601.
ISSN 0271-8235.
270
D
ow
nl
oa
de
d 
by
: E
lse
vie
r B
ib
lio
gr
ap
hi
c 
Da
ta
ba
se
s.
 C
op
yr
ig
ht
ed
 m
at
er
ia
l.
lithium. Ataxia may develop insidiously after many years on
the drug, even though the patient has normal serum levels
and lithium tremor may be absent.4,5 Subtle cerebellar signs
may be variably present, but might not be immediately
recognized. Recognition that lithium may be causing the
imbalance is important as this condition is mostly reversible
if the drug is stopped early. However, it may be irreversible if
there are complicating factors such as acute infection with
hyperthermia or concomitant use of neuroleptics.6
Valproate-Related Ataxia
Valproic acid is another drug well known to produce tremor
shortly after starting the drug.7 Reversible parkinsonism and
cognitive impairment are also recognizedwith a delayed onset
similar to what is seen with lithium.8 Reversible cerebellar
dysfunction that begins with gait ataxia has been seen with
this drug9 anyonewith a suspected neurodegenerative disease
that begins while on chronic valproate should be considered
for discontinuation even if (1) the individual has been taking
the drug for years, and (2) the drug levels are in the normal
range. The full improvement may take several months (similar
to tardive dyskinesia); consequently, the slow recovery after
cessation of the valproic acid is still consistentwith a cause and
effect relationship and should not be discounted until 6
months after discontinuation of the drug.
Amiodarone-Related Imbalance
Amiodarone is a drug used in the treatment of life-threatening
ventricular arrhythmias. In addition to pulmonary and thyroid
toxicity, neurologic side effects can be seen.10,11 Tremor, parkin-
sonism, and peripheral neuropathy are the most commonly
reported. Severe, progressive gait ataxia has been reported as
well and appears to be reversible upon stopping the drug.12–14
Bilateral Vestibular Hypofunction
Bilateral peripheral vestibular loss is an uncommonly recog-
nized cause of imbalance that may be acquired either from
degeneration, sequential bilateral vestibular neuritis, or from
ototoxicity, usually related to gentamicin. It can lead to un-
steadiness with few obvious neurologic signs. It can lead to
particularly difficult problems with imbalance in certain sub-
sets of patients with pre-existing somatosensory or visual
impairment. As an example, a diabetic patient with severe
longstanding polyneuropathy from diabetes may receive gen-
tamicin during a hospitalization for infection; after recovery
from the acute illness, the patient seems unable to regain the
ability tomaintain balance or walk safely due to vestibular loss.
The combination of vestibular and proprioceptive sensory loss
renders the patient severely off balance despite normal motor
power. Patients may report particular difficulty in darkness
(when deprived of vision) and sometimes oscillopsia (percep-
tion of “bouncy” vision during locomotion). Examination will
show an abnormal head impulse test in both directions and
severely reduced caloric vestibular responses.15 Bilateral ves-
tibular loss has a reasonably good long-term prognosis for
functional recovery when it is an isolated deficit.16
Tremor and Ataxia
Essential Tremor and Ataxia
Essential tremor is a very common neurologic condition
occurring in 5% of those over age 40.17–19 The incidence
increaseswith age andmaybe as high as 20% in those over the
age of 80. Gait and balance issues are common in advanced
age; it is often common to simply attribute instability to
aging, in the absence of any other clearly identified cause.
Table 1 Disorders that may present with gait ataxia
Toxins/drugs Infectious Metabolic Basal ganglia Genetic Autoimmune
Ethanol Creutzfeldt-Jakob
disease
B12 Early Parkinson’s disease Dominant Generalized
anxiety disorder
Phenytoin JC virus Wernicke’s
encephalopathy
Progressive
supranuclear palsy
Recessive Gluten sensitivity
Lithium Viral Multiple system atrophy Mitochondrial Hypothyroidism
Amiodarone Postviral Other Corticobasal
degeneration
X-linked Hashimoto’s
encephalopathy
Isoniazid Whipple’s Segawa’s disease DNA repair Paraneoplastic
Metronidazole Spinal arteriovenous
malformation
Miller-Fisher syndrome
Platens Structural
Cyclosporine Tumor
Valproic acid Demyelinating
Vascular
Abscess
Sarcoid
Hydrocephalus
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However, it is clear from several studies that some patients
with essential tremor are at ahigher risk fordevelopingdifficulty
walking; therefore, tremor and ataxia may correlate in some
individuals. A study of 36 essential tremor patients and 40 age-
matched controls demonstrated 50% of patients with essential
tremor had abnormalities of tandem gait compared with 28% of
controls. The abnormality was greater in those older than 70
(N ¼ 22) and those with essential tremor longer than 5 years
(N ¼ 28).20 It was suggested that this finding was related to the
reports of cerebellar dysfunction seen on blood flow imaging
studies,21 which has been confirmed in other studies subse-
quently.22,23 Another study followed up on the findings by
Singer et al to show a similar pattern of gait disturbance. This
study of 25 patients with essential tremor were analyzed with
kinematic analysis and compared with controls and those with
known cerebellar diseases.24 Findings in cases of essential
tremor were similar to those with cerebellar diseases, and
different from controls, with a widening of gait in normal
walking, changes in the heel strike pattern, and distinct prob-
lems with the balance of tandem gait. More abnormalities were
seen in those with intention tremor over postural tremor;
duration of disease did not seem to be a factor.
Follow-up studies have further examined the gait of
essential tremor. It seems as though it may be alcohol
responsive with improvement of tandem gait with modest
amount of ethanol compared with worsening of gait in
controls.25 Similarly, functional neurostimulation of the mo-
tor nucleus of the thalamus may improve gait in essential
tremor, independent of tremor control.26 These last two
studies taken together suggest that the gait abnormality of
essential tremor may be a functional disturbance rather than
pathologically mediated.
Orthostatic Tremor
Orthostatic tremor does not produce a gait disturbance per se,
but rather a disturbanceof stance.27 It is seen in older individuals
(mean age mid-50s) and is characterized clinically by repeated,
irregular buckling of the legs and leg crampswhile the patient is
maintaining stance.28 There is often latency of onset of buckling
of up to 3 minutes. Underlying the buckling is a high-frequency
tremor that may be picked up by electromyography, but is
usually not observed because of it fine, rapid nature. Because
of the frequency range of the tremor (13–18 Hz), the tremor
might also be audible with a stethoscope as a low thumping
sound.29 Orthostatic tremor can be seen with parkinsonism in
25% of cases and is associated with essential tremor is some
studies30; however, it is most commonly idiopathic.28 It often
responds to treatment with clonazepam or gabapentin, so this
condition should not be overlooked.31
Fragile X-Associated Tremor/Ataxia
Syndrome
Fragile X-associated tremor/ataxia syndrome is a late-onset
neurodegenerative disorder presenting in men over the age
of 50. It occurs in carriers of a premutation range expansion of
the CGG-repeat causative of fragile X mental retardation (X-
linked recessive disorder). The disorder typically begins with
action tremor followed bygait ataxiawithin 2 to 3 years.With
progression, there may be parkinsonism, dementia, periph-
eral neuropathy, and autonomic impairment. Magnetic reso-
nance imaging may only show hyperintensity in the middle
cerebellar peduncles. Family history of mental retardation in
cousins and grandchildren may be present. The carrier fre-
quency of the premutation in the general population is
estimated at 1 in 213 for females and 1 in 813 in males.32
Penetrance is age related with 75% of male carriers manifest-
ing symptoms once over 80 years old.33 This makes this
condition similar in prevalence to multiple system atrophy
and amyotrophic lateral sclerosis. It seems to be rare in pure
presentations of various movement disorders. For instance,
the FMR1 premutation is rare to absent in classic essential
tremor and Parkinson’s disease.34,35 However, screening a
cerebellar type of multiple system atrophy and late-onset
cerebellar ataxia in men may produce a positive rate of 5%.36
Based on these types of studies, a review has suggested that
FMR1 premutation screening be performed in cerebellar
ataxia of unknown cause in individuals over the age of 50.37
Other Genetic Ataxias in Late Adulthood
Episodic ataxia type 2 (EA-2) is a genetic disorder that leads to
episodes of dizziness and ataxia. In some patients, there are
no neurologic abnormalities evident between attacks, where-
as in others, there is a slowly progressive ataxia that develops
between the attacks characterized by downbeat and or gaze-
evoked nystagmus and gait ataxia. EA-2 is associated with
more than 20 distinct CACNA1A mutations and the list is
growing.38 SCA 6 is allelic with episodic ataxia 2 (EA-2) and
there appears to be some phenotypic overlap between the
two conditions with some patients initially having an inter-
mittent ataxia before going on to develop a more chronic,
progressive course.39–41 It presents as a relatively pure cere-
bellar ataxiawith gait often affected first. Noncerebellar signs
occur less frequently and include decreased vibration/propri-
oception and impaired upgaze. The frequency of SCA6 ismore
common in Japanese and German ataxia families.42 Because
of the older age of onset (mid-50s) and relatively normal life
span, family history may not be immediately obvious; up to
30% of SCA6 may be mislabeled as sporadic ataxia. The
episodic ataxia may be responsive to acetazolamide and
perhaps in some instances 4-aminopyridine.43
The autosomal recessive adult cerebellar ataxias include
late-onset Friedrich’s ataxia and α-tocopherol (vitamin E)
deficiency. Both produce an indistinguishable clinical pheno-
type characterized ataxia with signs of posterior column
involvement, areflexia, and extensor plantar responses.44
Autoimmune-Mediated Ataxia
Gluten Ataxia
It has been recognized for some time that celiac disease may
be associated with neurologic manifestations including sen-
sory neuropathy and ataxia.45 However, in the last 10 to
15 years, it has become clear that these neurologic disorders
Seminars in Neurology Vol. 33 No. 3/2013
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can present even in the absence of malabsorption or other
gastrointestinal symptoms.46 These patients present with
severe gait ataxia without other cerebellar findings. Some
have a sensory neuropathy or ganglionopathy.47 Gluten sen-
sitivity may be detected by the presence of antigliadin anti-
bodies (IgA/IgG) and tissues transglutaminase. Intestinal
biopsy may show lymphocytic infiltration and changes typi-
cal of celiac disease even without classic gastrointestinal
symptoms in 75%.48 Approximately 30% of sporadic ataxia
may show antibodies to gluten compared with 10% of
controls.49–51
What is not entirely clear is whether the antibodies are
causative of ataxia ormerely epiphenomena. However, recent
studies have suggested that the gluten sensitivity may be
pathogenic as there are now several reports of the neurologic
condition stabilizing or even improving with strict adherence
to a gluten-free diet.47,52,53 Additionally, treatment with
intravenous immunoglobulin may be of benefit.54 Based on
these studies, it is recommended that patients with sporadic
ataxia and/or progressive sensory ganglionopathy be
screened for antigliadin antibodies. Those positive should
be considered for dietary management. Follow-up with peri-
odic antibody testing is crucial to ensure dietary compliance.
Hashimoto’s Encephalopathy (Autoimmune
Thyroiditis)
Patients with Hashimoto’s encephalopathy present with a
variety of neurologic and psychiatric symptoms including
tremor, confusion, seizures, and psychiatric symptoms. Atax-
ia has also been reported as a primary manifestation of
autoimmune thyroiditis.55,56 Patients present with a sub-
acute or chronic cerebellar process. There may be a history of
other organ-specific autoimmune disorders. Imaging may
show cerebellar atrophy in more chronic patients. Laboratory
testing shows elevated levels of antithyroglobulin and anti-
thyroid peroxidase antibodies. Prednisonemay result in rapid
improvement in some,56 but not all55 patients. Some patients
may respond to intravenous immunoglobulin.55
Paraneoplastic Disorders
The acute to subacute onset of gait ataxia with normal
imaging should prompt consideration of a paraneoplastic
disorder. Anti-Yo (gynecological cancers and Hodgkin’s lym-
phoma) and anti-Ri (neuroblastoma) can both produce a
cerebellar disorder.57,58 Anti-Hu (small-cell lung cancer)
can produce a cerebellar ataxia syndrome, usually with
cerebellar examination abnormalities, including ataxic gait,
limb clumsiness, impaired pursuit eye movement tracking,
and gaze-evoked nystagmus. Anti-Hu antibodies may also
result in other paraneoplastic neurologic syndromes includ-
ing sensory neuronopathy (Denny-Brown syndrome) and
limbic encephalitis.59 Overlap of the various clinical syn-
dromes can be seen such that antibody screening is best
performed more globally unless the underlying cancer is
already known. Onset of the neurologic disorder can precede
the detection of the underlying cancer by months to years in
approximately two-thirdswhereas the rest are seenwhen the
cancer has been treated and may be no longer detectable.
Periodic cancer screening should be performed in anyone
with positive antibodies where the cancer was not detectable
on initial evaluation.
Gait Abnormality with Hyperreflexia and
Normal Imaging
Adult-Onset Dopa-Responsive Dystonia (Segawa’s
Disease)
Dopa-responsive dystonia is an autosomal dominant dystonia
that usually begins in the first decade of life as the child
begins to walk.60,61 Infrequently, however, the onset of
symptoms can occur much later in life,62 resulting in a very
long interval between onset of symptoms and an actual
diagnosis.63 The symptoms consist of gait disturbance cate-
gorized by toewalking and sometimes torsion dystonia of the
lower limbs later involving the upper extremities. Over
decades, patients may develop postural tremor and mild
parkinsonian features (except rest tremor). A key feature in
children is the clinical symptoms have marked diurnal varia-
tion with exacerbation of symptoms in the evening and often
complete resolution by morning after sleep. Another feature
is that of hyperreflexia with flexor plantar reflexes, slow
movements, stiffness, and balance difficulty.
The most common genetic abnormality seen in dopa-
responsive dystonia is guanosine triphosphate cyclohydro-
lase I deficiency.With identification of a causative gene, other
phenotypes have been identified including a later age of
onset, a more focal task specific dystonia or even simple
parkinsonism.64
Onset after the age of 18 seems to be rare, perhaps less
than 10%, but the disorder can be seen as late as the sixth
decade. In addition, the gene has variable penetrance such
that a family history might be absent. Treatment is with
carbidopa/levodopa and the response is typically quite dra-
matic. Patients remain medication responsive and usually do
not develop motor fluctuations or dyskinesias as with typical
Parkinson’s disease. Often, by the fourth decade, levodopa can
be weaned successfully. Other conditions may mimic dopa-
responsive dystonia including hereditary spastic paraparesis,
Wilson’s disease, cerebral palsy, and Parkin mutation (young-
onset recessive Parkinson’s disease). Because of the unique
sensitivity of this disorder to treatment, a trial of levodopa
should be considered in a patient of any age presenting with a
gait disturbance characterized by lower extremity stiffness
and hyperreflexia without causative central nervous system
abnormality on imaging. The peculiar appearance of the gait
may sometimes lead to the erroneous diagnosis of a conver-
sion disorder or psychiatric gait disorder.
Spinal Dural Arteriovenous Fistula
These lesions represent the majority of spinal vascular mal-
formations. The most common clinical presentation is that of
an often fluctuating, progressive myelopathy in middle-aged
men. Clinical signs are due to venous congestion causing cord
compromise. Findings on MRI may be missed or absent on
traditional sequences; magnetic resonance angiography may
be helpful, but neither replaces the need for arteriography.65
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Findings on traditional MRI may only show subtle T2 hyper-
intensity (80%); flow voids can usually be seen, but require
especially careful inspection (89%).66 The presence of either of
these two features has a sensitivity of 100% in predicting an
arteriovenous fistula at arteriography or surgery. The identi-
fication of these lesions is crucial as successful treatment can
stabilize or improve disability.67
Nutrient and Mineral Malabsorption Syndromes
It should be remembered that in patients with spasticity and
gait difficulty with a prior history of bariatric surgery or who
may be prone to short bowel malabsorption, should be
assessed for copper deficiency-relatedmyelopathy or vitamin
E or B12 deficiency states.68
Conclusion
There are many causes of gait ataxia. Many of these can be
identified based on the presence of additional neurologic
findings as well as findings on imaging and neurophysiologi-
cal studies. When no cause is immediately evident, the
etiology may declare itself over time and close follow-up is
warranted.
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